C4 Therapeutics
Develops targeted-protein degraders for oncology through TORPEDO.
$3.91
After-hours close+0.06 (+1.54%)
At close$3.85(−6.10%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.21 | — | — |
| Aug 2026 | −$0.23 | −$0.18 | +20.5% |
| May 2026 | −$0.25 | −$0.20 | +20.2% |
| Feb 2026 | −$0.31 | −$0.18 | +41.9% |
| Nov 2025 | −$0.47 | −$0.44 | +6.4% |
The latest year is open to everyone — the 26 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Oct 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Oct 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | −$0.21 | — | — | $8.8M | — | — |
| Aug 11, 2026 | −$0.23 | −$0.18 | +20.5% | $4.0M | $6.6M | +66.0% |
| May 12, 2026 | −$0.25 | −$0.20 | +20.2% | $4.4M | $6.2M | +40.4% |
| Feb 26, 2026 | −$0.31 | −$0.18 | +41.9% | $5.4M | $11.0M | +104.2% |
| Nov 6, 2025 | −$0.47 | −$0.44 | +6.4% | $4.5M | $11.2M | +150.7% |
The latest year is open to everyone — the 26 quarters behind it read with an account. Sign in | ||||||
| Aug 7, 2025 | ||||||
| May 7, 2025 | ||||||
| Feb 27, 2025 | ||||||
| Oct 31, 2024 | ||||||
| Aug 1, 2024 | ||||||
| May 8, 2024 | ||||||
| Feb 22, 2024 | ||||||
| Nov 1, 2023 | ||||||
| Aug 8, 2023 | ||||||
| May 4, 2023 | ||||||
| Feb 23, 2023 | ||||||
| Nov 3, 2022 | ||||||
| Aug 4, 2022 | ||||||
| May 5, 2022 | ||||||
| Feb 24, 2022 | ||||||
| Nov 10, 2021 | ||||||
| Aug 11, 2021 | ||||||
| May 13, 2021 | ||||||
| Mar 11, 2021 | ||||||
| Nov 12, 2020 | ||||||
| Oct 2, 2020 | ||||||
| Mar 31, 2020 | ||||||
| Dec 31, 2019 | ||||||
| Sep 30, 2019 | ||||||
| Jun 30, 2019 | ||||||
| Mar 31, 2019 | ||||||